Intellia Therapeutics - 53 Year Dividend History | NTLA
Historical dividend payout and yield for Intellia Therapeutics (NTLA) since 1971. The current TTM dividend payout for Intellia Therapeutics (NTLA) as of December 20, 2024 is $0.00. The current dividend yield for Intellia Therapeutics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.314B |
$0.036B |
|
Intellia Therapeutics is a leading clinical-stage genome editing company focused on developing CRISPR/Cas9-based therapeutics. The company is pursuing two primary approaches to fully realize the transformative potential of CRISPR/Cas9 in vivo programs that use intravenously administered CRISPR as the therapy and ex vivo programs that use CRISPR to create the therapy by using engineered human cells.?
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
